It works by: Slowing how quickly your stomach empties Reducing appetite and cravings Encouraging better portion control Supporting insulin when sugar is present Improving how your body burns and stores energy GLP-1 is not insulin
A systematic review specifically examining tirzepatide found no significantly increased risk of pancreatitis compared to control groups including placebo, basal insulin, and selective GLP-1 receptor agonists
The Takeaway GLP-1 plays a key role in weight management by helping you feel fuller, slowing digestion, and stabilizing blood sugar, making appetite control more manageable
#AddictionResearch #Neuroscience #GLP1 #Endocrinology #SubstanceUseDisorders #CitationAnalysis #ScientificLiterature #ResearchWorkflow #Scite To view or add a comment, sign in With $285M from its IPO, LB Pharmaceuticals Inc will fund new trials of its investigational drug LB-102 for schizophrenia and bipolar depression
Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy
The development of affordable and accurate quantitative enzyme POCTs will enable greater opportunities for a more extensive coverage in newborn screening for G6PD deficiency